Anna N.H. Walstra , Harriet L. Lancaster , Marjolein A. Heuvelmans , Carlijn M. van der Aalst , Juul Hubert , Dana Moldovanu , Sytse F. Oudkerk , Daiwei Han , Jan Willem C. Gratama , Mario Silva , Harry J. de Koning , Matthijs Oudkerk
{"title":"《人工智能在4-IN-THE-LUNG-RUN肺癌筛查试验中作为第一阅读器的可行性:对阴性错误分类和临床转诊率的影响》,《欧洲癌症杂志》,第216卷,2025年2月5日,115214","authors":"Anna N.H. Walstra , Harriet L. Lancaster , Marjolein A. Heuvelmans , Carlijn M. van der Aalst , Juul Hubert , Dana Moldovanu , Sytse F. Oudkerk , Daiwei Han , Jan Willem C. Gratama , Mario Silva , Harry J. de Koning , Matthijs Oudkerk","doi":"10.1016/j.ejca.2025.115294","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"218 ","pages":"Article 115294"},"PeriodicalIF":7.9000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to: Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: Impact on negative-misclassifications and clinical referral rate, European Journal of Cancer, Volume 216, 5 February 2025, 115214\",\"authors\":\"Anna N.H. Walstra , Harriet L. Lancaster , Marjolein A. Heuvelmans , Carlijn M. van der Aalst , Juul Hubert , Dana Moldovanu , Sytse F. Oudkerk , Daiwei Han , Jan Willem C. Gratama , Mario Silva , Harry J. de Koning , Matthijs Oudkerk\",\"doi\":\"10.1016/j.ejca.2025.115294\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"218 \",\"pages\":\"Article 115294\"},\"PeriodicalIF\":7.9000,\"publicationDate\":\"2025-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0959804925000759\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804925000759","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Corrigendum to: Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: Impact on negative-misclassifications and clinical referral rate, European Journal of Cancer, Volume 216, 5 February 2025, 115214
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.